Role of GSK-3 and T-bet in anti-tumor immunity
Le facteur de transcription T-bet joue un rôle central dans la régulation de la différenciation des lymphocytes T. La protéine tyrosine kinase, la glycogène synthase kinase 3 (GSK-3), inhibe l'activation des lymphocytes T et contrôle l'expression de leurs récepteurs inhibiteurs PD-1 et LAG...
Main Author: | Cherukommu, Shirisha |
---|---|
Other Authors: | Rudd, Christopher E. |
Format: | Others |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/1866/25645 |
Similar Items
-
Investigation of the anti-migratory properties of GSK-3 inhibitors in glioblastoma
by: Rolfs, Hillary
Published: (2016) -
Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response
by: Andre De Souza, et al.
Published: (2020-10-01) -
TEST-SYSTEM FOR ESTIMATION OF ACTIVITY OF GSK-3 INHIBITORS AS ANTIHYPOXANTS AND DIFFERENTIATION OF ENDOTHELIAL PROGENITORS IN VITRO
by: Youri Burda, et al.
Published: (2016-03-01) -
Increase in Subcellular GSK-3 Clusters in Insulin- and Adrenaline-treated Differentiated Rat Skeletal Muscle Fibres
by: Katja Fink, et al.
Published: (2020-04-01) -
Macrophage Function and the Role of GSK3
by: Sarvatit Patel, et al.
Published: (2021-02-01)